NDA-enabling phase I lofexidine program
Ended Cooperative Agreement Awarded Last action
- Award ID
- U01DA030916
- Recipient
-
MDD US Operations, LLC UEI NKGSYBV5UGN1
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $5,081,734
Award facts
- Assistance listing
- 93.279 Drug Use and Addiction Research Programs
- Completion date
- Originally
- Place of performance
- Brownsboro Village, KY 40207, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $1,438,532 | |
| Amendment | $91,375 | |
| Amendment | $184,531 | |
| Amendment | $57,666 | |
| Amendment | $864,989 | |
| Amendment | $468,517 | |
| Amendment | $976,880 | |
| Original award | $999,244 |
Quick answers
Who received award U01DA030916?
U01DA030916 was awarded to MDD US Operations, LLC by National Institutes of Health (Department of Health and Human Services) on March 1, 2011.
How much is award U01DA030916 worth?
$5,081,734 has been obligated on U01DA030916.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award